Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,606 USD | -5,21% | +22,44% | -56,83% |
Vakgebied
Aantal werknemers: 16
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | nan % | 2 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 2 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 01-01-87 |
Director of Finance/CFO | 52 | 01-01-19 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 66 | - | |
Anthony Marciano
IRC | Investor Relations Contact | - | 01-08-17 |
Lucas Pilipski
PRN | Corporate Officer/Principal | - | 01-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 01-09-21 | |
Richard Pascoe
BRD | Director/Board Member | 60 | 01-03-13 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 01-01-19 |
Brian Lian
BRD | Director/Board Member | 58 | 01-01-19 |
Raj Mehra
CEO | Chief Executive Officer | 64 | 01-01-87 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 13 680 576 | 13 406 690 ( 98,00 %) | 0 | 98,00 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
REGNUM CORP. 98.82% | 22 680 000 | 98.82% | 725 760 $ |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,83% | 8,75 mln. | |
+34,10% | 701 mld. | |
+26,24% | 571 mld. | |
+1,28% | 381 mld. | |
+21,15% | 334 mld. | |
+17,25% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,16% | 157 mld. |
- Beurs
- Aandelen
- Aandeel Seelos Therapeutics, Inc. - Nasdaq
- Onderneming Seelos Therapeutics, Inc.